Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal study.
The Alice in Wonderland syndrome: an unusual in acute disseminated encephalomyelitis.
Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat.
Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients.
Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action.
Multiple sclerosis: Five new things.
Compassionate Use Programme Update
Epigenetic changes in neurology: DNA methylation in multiple sclerosis.
Neuroprotection With Riluzole Patients With Early Multiple Sclerosis
Biologically plausible and evidence-based risk intervals in immunization safety research.
AP-1 Mediated Transcriptional Repression of Matrix Metalloproteinase-9 by Recruitment of Histone Deacetylase 1 in Response to Interferon β.
Astrocyte proliferation is regulated by the OGF-OGFr axis in vitro and in experimental autoimmune encephalomyelitis.
Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod.
Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab.
Placebo Cohorts in Phase-3 MS Treatment Trials - Predictors for On-Trial Disease Activity 1990-2010 Based on a Meta-Analysis and Individual Case Data.
Mechanisms in the Development of Multiple Sclerosis Lesions: Reconciling Autoimmune and Neurodegenerative Factors.
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis.
Multiple Sclerosis and Venous Abnormalities: Medicine in the Age of Social Media.
Modulation of the Innate Immune Response by Human Neural Precursors Prevails Over Oligodendrocyte Progenitor Remyelination to Rescue a Severe Model Of Pelizaeus-Merzbacher Disease.
Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivation.
Deletion of IL-4Rα in the BALB/c mouse is associated with altered lesion topography and susceptibility to experimental autoimmune encephalomyelitis.
Assessment of neuroactive steroids in cerebrospinal fluid comparing acute relapse and stable disease in relapsing-remitting multiple sclerosis.
Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS.
The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability.
Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis.
Pages
« first
‹ previous
…
173
174
175
176
177
178
179
180
181
…
next ›
last »